The biotech bi-weekly: kicking off 2026 with genomic drug discovery, organoid development and ADC characterization

The biotech industry has certainly hit the ground running in 2026. In its first edition of the year, the biotech bi-weekly highlights new products that can visualize multimodal biological data at scale, streamline antibody–drug conjugate (ADC) characterization and perform agentic genomic drug discovery. Plus, recent partnerships are driving next-generation therapeutics development, accelerating data-driven insights into cancer treatment and promoting solutions for organoid development. Products Visualizing multiomic and multimodal biological data at scale Illumina (CA, USA) has announced the release of Illumina Connected Multiomics, a powerful cloud-based research software platform to analyze and visualize multiomic and multimodal biological data at scale....